Retracted] MicroRNA‑203 inhibits the proliferation and invasion of U251 glioblastoma cells by directly targeting PLD2

Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that the PLD2 western blotting data shown in Fig. 3A and the Transwell invasion assay data shown in Fig. 6 were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes that had either already been published elsewhere prior to the submission of this paper to Molecular Medicine Reports, or were under consideration for publication at around the same time. In view of the fact that certain of these data had already apparently been published previously, the Editor of Molecular Medicine Reports has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 9: 503‑508, 2014; 10.3892/mmr.2013.1814].

Errataetall:

RetractionOf: Mol Med Rep. 2014 Feb;9(2):503-8. - PMID 24270883

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:29

Enthalten in:

Molecular medicine reports - 29(2024), 2 vom: 23. Jan.

Sprache:

Englisch

Beteiligte Personen:

Chen, Zigui [VerfasserIn]
Li, Dazhi [VerfasserIn]
Cheng, Quan [VerfasserIn]
Ma, Zhiming [VerfasserIn]
Jiang, Bing [VerfasserIn]
Peng, Renjun [VerfasserIn]
Chen, Rui [VerfasserIn]
Cao, Yiqiang [VerfasserIn]
Wan, Xin [VerfasserIn]

Links:

Volltext

Themen:

Glioblastoma
Glioma
Invasion
MicroRNA-203
Phospholipase D2
Proliferation
Retraction of Publication

Anmerkungen:

Date Revised 14.01.2024

published: Print-Electronic

RetractionOf: Mol Med Rep. 2014 Feb;9(2):503-8. - PMID 24270883

Citation Status PubMed-not-MEDLINE

doi:

10.3892/mmr.2023.13154

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM366769243